Correlation of lesional uptake parameters and ratios with miPSMA score and estimating normal physiologic concentration: an exploratory analysis in metastatic …
A Kalshetty, B Menon, S Rakshit… - Journal of nuclear …, 2021 - Soc Nuclear Med
The use of prostate-specific membrane antigen (PSMA)–based PET/CT has grown rapidly in
recent years. This study estimated lesional uptake, normal physiologic concentrations, and …
recent years. This study estimated lesional uptake, normal physiologic concentrations, and …
Matched-pair comparison of 68Ga-PSMA-11 and 18F-rhPSMA-7 PET/CT in patients with primary and biochemical recurrent prostate cancer
I Rauscher, M Kronke, A Wurzer, H Wester, W Weber… - 2020 - Soc Nuclear Med
42 Purpose: 18 F-labeled prostate-specific membrane antigen (PSMA)-ligand positron
emission tomography/computed tomography (PET/CT) is increasingly used for prostate …
emission tomography/computed tomography (PET/CT) is increasingly used for prostate …
The increased prevalence of low and heterogeneous PSMA uptake in the setting of metastatic castration-resistant prostate cancer.
D Lin, I De Kouchkovsky, R Aggarwal, T Hope - 2021 - Soc Nuclear Med
1349 Objectives: Prostate-specific membrane antigen (PSMA) has shown superior accuracy
over conventional imaging modalities and FDG-PET in the initial staging of patients with …
over conventional imaging modalities and FDG-PET in the initial staging of patients with …
Comparative assessment of 18F-PSMA-1007 PET/CT biodistribution in prostate cancer at 60 and 120 minutes: Quantitative analysis
M Al-Daas, B Al-Enezi, A Esmail, F Marafi - 2019 - Soc Nuclear Med
3051 Introduction: Prostate specific membrane antigen (PSMA) is significantly
overexpressed with prostate cancer patients. The prostate-specific membrane antigen …
overexpressed with prostate cancer patients. The prostate-specific membrane antigen …
Preliminary comparative study between 18F-PSMA-1007 and 68Ga-PSMA-11 PET/CT in patients with prostate cancer: biodistribution and tumor detection
S Chen, YH Wong, TT Tsoi, YL Leung, KC Cheng… - 2019 - Soc Nuclear Med
590 Objectives: 68 Ga-PSMA-11 (prostate-specific membrane antigen) PET/CT has recently
showed significant impact in the management of prostate cancer (PCa). The main …
showed significant impact in the management of prostate cancer (PCa). The main …
Prognostic value of end-of-treatment PSMA PET/CT in patients treated with 177Lu-PSMA radioligand therapy: a retrospective, single-center analysis
Our objective was to evaluate the prognostic value of end-of-treatment prostate-specific
membrane antigen (PSMA) PET/CT (PSMA-PET) in patients with metastatic castration …
membrane antigen (PSMA) PET/CT (PSMA-PET) in patients with metastatic castration …
The impact of peptide amount on tumor uptake to assess PSMA receptor saturation on 68Ga-PSMA-11 PET/CT in patients with primary prostate cancer
H Siebinga, J olde Heuvel, EJ Rijkhorst… - Journal of Nuclear …, 2023 - Soc Nuclear Med
68Ga-labeled prostate-specific membrane antigen (PSMA) is often produced on-site, where
usually a fixed amount of peptide is conjugated to the generator eluate. However …
usually a fixed amount of peptide is conjugated to the generator eluate. However …
[HTML][HTML] PSMA Expression Predicts Early Biochemical Response in Patients with Metastatic Castration-Resistant Prostate Cancer under 177Lu-PSMA-617 …
L Widjaja, RA Werner, TL Ross, FM Bengel, T Derlin - Cancers, 2021 - mdpi.com
Simple Summary Prostate-specific membrane antigen (PSMA) is a promising target for both
imaging and radioligand therapies (RLT) for men with prostate cancer. However, not all …
imaging and radioligand therapies (RLT) for men with prostate cancer. However, not all …
Performance of the novel 18F-labeled prostate-specific membrane antigen-ligand PSMA-7 for PET/CT in prostate cancer patients
M Dietlein, M Hohberg, C Kobe, F Dietlein… - 2018 - Soc Nuclear Med
452 Objectives: We evaluated the sensitivity of the novel 18 F-labeled PSMA-ligand 18 F-
PSMA-7 for PET/CT imaging of prostate cancer patients. Methods: In this IRB-approved …
PSMA-7 for PET/CT imaging of prostate cancer patients. Methods: In this IRB-approved …
Radiation dosimetry for 177Lu-PSMA I&T in metastatic castration-resistant prostate cancer: absorbed dose in normal organs and tumor lesions
S Okamoto, A Thieme, J Allmann… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA)–targeted radioligand therapy is increasingly
used in metastatic castration-resistant prostate cancer. We aimed to estimate the absorbed …
used in metastatic castration-resistant prostate cancer. We aimed to estimate the absorbed …
Related searches
- 177lu psma radioligand therapy
- 177lu psma normal organs
- 68ga psma prostate cancer
- 68ga psma tumor uptake
- 68ga psma peptide amount
- tumor lesions normal organs
- normal organs radiation dosimetry
- normal organs absorbed dose
- normal organs prostate cancer
- 177lu psma tumor lesions
- radioligand therapy prostate cancer
- 177lu psma radiation dosimetry
- 177lu psma absorbed dose
- radioligand therapy prognostic value
- 177lu psma prognostic value
- 68ga psma tumor detection